These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9031878)

  • 21. Failure of ceftibuten to alter single dose theophylline clearance.
    Bachmann K; Schwartz J; Jauregui L; Martin M; Nunlee M
    J Clin Pharmacol; 1990 May; 30(5):444-8. PubMed ID: 2347955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy, safety, and tissue penetration of solithromycin in Japanese patients with otorhinolaryngological infections.
    Kurono Y; Kudo F; Watanabe A; Yamatake T; Shimada S; Suzuki K
    Auris Nasus Larynx; 2024 Apr; 51(2):379-390. PubMed ID: 38065757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tonsillar Helicobacter pylori colonization in chronic tonsillitis: systematic review and meta-analysis.
    Hwang MS; Forman SN; Kanter JA; Friedman M
    JAMA Otolaryngol Head Neck Surg; 2015 Mar; 141(3):245-9. PubMed ID: 25541915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil.
    Gehanno P; Andrews JM; Ichou F; Sultan E; Lenfant B
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():47-51. PubMed ID: 2292530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tonsillar tissue penetration of dirithromycin after multiple doses.
    Benson JM; Arnold J; Manning SC; Coleman DL; Sides GD; Conforti PM; Lemon E; Watkins VS
    J Clin Pharmacol; 1996 Sep; 36(9):832-7. PubMed ID: 8889904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptosis in chronic tonsillitis and tonsillar hypertrophy.
    Önal M; Yılmaz T; Bilgiç E; Müftüoğlu SF; Kuşçu O; Günaydın RÖ
    Int J Pediatr Otorhinolaryngol; 2015 Feb; 79(2):191-5. PubMed ID: 25555639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tonsillotomy or tonsillectomy?--a prospective study comparing histological and immunological findings in recurrent tonsillitis and tonsillar hyperplasia.
    Reichel O; Mayr D; Winterhoff J; de la Chaux R; Hagedorn H; Berghaus A
    Eur Arch Otorhinolaryngol; 2007 Mar; 264(3):277-84. PubMed ID: 17021780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peritonsillar abscess: clinical aspects of microbiology, risk factors, and the association with parapharyngeal abscess.
    Klug TE
    Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of phenoxymethylpenicillin in tonsils.
    Roos K; Grahn E; Ekedahl C; Holm SE
    Scand J Infect Dis; 1986; 18(2):125-30. PubMed ID: 3085212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concentrations of ceftibuten in bronchial secretions.
    Scaglione F; Triscari F; Demartini G; Arcidiacono M; Cocuzza C; Fraschini F
    Chemotherapy; 1995; 41(4):229-33. PubMed ID: 7555201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The penetration of ceftibuten into the respiratory tract.
    Krumpe P; Lin CC; Radwanski E; Cayen MN; Affrime MB
    Chest; 1999 Aug; 116(2):369-74. PubMed ID: 10453864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fibrinolytic activity of blood and tonsillar tissue in patients with chronic tonsillar tissue in patients with chronic tonsillitis after tonsillectomy with local use of epsilon-aminocaproic acid].
    Gadziev MK
    Vestn Otorinolaringol; 1975; (3):71-2. PubMed ID: 1146118
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
    Nix DE; Symonds WT; Hyatt JM; Wilton JH; Teal MA; Reidenberg P; Affrime MB
    Pharmacotherapy; 1997; 17(1):121-5. PubMed ID: 9017772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children.
    Kearns GL; Reed MD; Jacobs RF; Ardite M; Yogev RD; Blumer JL
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2078-84. PubMed ID: 1759830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short course therapy with cefitbuten versus azithromycin in pediatric streptococcal pharyngitis.
    Boccazzi A; Tonelli P; De'Angelis M; Bellussi L; Passali D; Careddu P
    Pediatr Infect Dis J; 2000 Oct; 19(10):963-7. PubMed ID: 11055597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic drug interaction study: administration of ceftibuten concurrently with the antacid mylanta double- strength liquid or with ranitidine.
    Radwanski E; Nomeir A; Cutler D; Affrime M; Lin CC
    Am J Ther; 1998 Mar; 5(2):67-72. PubMed ID: 10099040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent tonsillitis and tonsillectomy in juvenile idiopathic arthritis.
    Astrauskiene D; Bernotiene E; Bytautiene J; Sakalinskas V; Panaviene V; Venaliene J; Lesinskas E
    Scand J Rheumatol; 2009; 38(5):349-52. PubMed ID: 19579150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Explaining the poor bacteriologic eradication rate of single-dose ceftriaxone in group a streptococcal tonsillopharyngitis: a reverse engineering solution using pharmacodynamic modeling.
    Blumer JL; Reed MD; Kaplan EL; Drusano GL
    Pediatrics; 2005 Oct; 116(4):927-32. PubMed ID: 16199703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteriologic comparison of tonsil core in recurrent tonsillitis and tonsillar hypertrophy.
    Jeong JH; Lee DW; Ryu RA; Lee YS; Lee SH; Kang JO; Tae K
    Laryngoscope; 2007 Dec; 117(12):2146-51. PubMed ID: 17909446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of matrix metalloproteinases in recurrent tonsillitis.
    Acioglu E; Yigit O; Alkan Z; Server EA; Uzun H; Gelisgen R
    Int J Pediatr Otorhinolaryngol; 2010 May; 74(5):535-9. PubMed ID: 20233630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.